Tech Company Financing Transactions

OncoMyx Therapeutics Funding Round

OncoMyx Therapeutics secured a $25 million Series A investment round on 6/6/2019. Investors included Boehringer Ingelheim Venture Fund, Delos Capital and Xeraya Capital.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

445 N. 5th St.
Phoenix, AZ 85004
USA

Phone

Undisclosed

Website

www.oncomyx.com

Email Address

[email protected]

Overview

OncoMyx Therapeutics is developing oncolytic immunotherapies based on the myxoma virus (MYXV) platform to orchestrate an immune response and treat cancer. Successful immuno-oncology (IO) cancer treatment generally requires combination therapy, and oncolytic viruses (OVs) have emerged as a safe and effective IO complement.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Steve Potts

        

Chief Operating Officer

Michael Wood

        

Chief Scientific Officer

Leslie Sharp

        

VP - R & D

Grant McFadden

        

Browse more venture capital transactions:

Prev: 6/6/2019: SentinelOne venture capital transaction
Next: 6/6/2019: Spiro venture capital transaction

Share this article

About Database of VC Transactions

We do our best to record every notable VC transaction. All VC database entries reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary